Request for information
Submit your technology to Trials@Home
Trials@Home (EU/EFPIA Innovative Medicines Initiative – Joint Undertaking (H2020-JTI-IMI2) Trials@Home grant n° 831458) aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of remote decentralised clinical trials (RDCTs) in Europe.
Identifying existing RCDT solutions
In this current stage we are exploring and mapping:
- existing RDCT technologies across-the-board in any stage of the RCT
- specific diabetes-oriented technologies, that can be deployed in RDCT approaches
To support our search we provide the opportunity for companies to submit their technologies in any of the areas listed below, or indicate that the technology or service is applicable in multiple / other areas.
What happens when you submit your solution?
Information will be saved and classified in a secured Trials@Home (technology scan) database. You will be contacted if there are any questions and if we would like to proceed in further discussions about your solution(s).
More information or advice ?
Contact us by email.